Press Release: Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026

Dow Jones07-10
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--July 09, 2026--

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the second quarter 2026 after the close of market on Thursday, July 30, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.

The conference call will be webcast live from the company's website and will be available via the following link: https://edge.media-server.com/mmc/p/wwu2pyd7. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company's website at https://investor.veracyte.com/events-presentations.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for patients around the world. The company's molecular tests assess the unique biology of each patient's tumor to help clinicians answer essential questions about cancer care. Veracyte's Diagnostics Platform combines broad genomic and clinical data, advanced bioinformatics and AI, and a powerful evidence-generation engine to support continued innovation and pipeline development. The company's portfolio includes the Afirma$(R)$ Genomic Sequencing Classifier test, Decipher(R) Bladder Genomic Classifier test, Decipher(R) Prostate Genomic Classifier test, Prosigna(R) Breast Risk of Recurrence test, and the TrueMRD$(TM)$ Monitoring Test for MIBC. For more information, visit Veracyte's website or follow the company on LinkedIn or X (Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20260709945913/en/ 

 
    CONTACT:    Investors

Kelly Gura

investors@veracyte.com

Media

Molly Cornbleet

media@veracyte.com

+1-650-351-8780

(END) Dow Jones Newswires

July 09, 2026 17:10 ET

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment